Premium
Possible role of the mitochondrial genome in the pathogenesis of autosomal dominant polycystic kidney disease
Author(s) -
Saravanabavan Sayanthooran,
Rangan Gopala K.
Publication year - 2021
Publication title -
nephrology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.752
H-Index - 61
eISSN - 1440-1797
pISSN - 1320-5358
DOI - 10.1111/nep.13957
Subject(s) - autosomal dominant polycystic kidney disease , pkd1 , pathogenesis , mitochondrial dna , disease , genetics , medicine , polycystic kidney disease , phenotype , mitochondrial disease , genome , bioinformatics , gene , biology , pathology
Autosomal dominant polycystic kidney disease (ADPKD) is the most common monogenic renal disease in adults and is due to heterozygous germ line variants in either PKD1 , PKD2 or rarely other genes. It is characterized by marked intra‐familial disease variability suggesting that other genetic and/or environmental factors are involved in determining the lifetime course ADPKD. Recently, research indicates that polycystin‐mediated mitochondrial dysfunction and metabolic re‐programming contributes to the progression of ADPKD. Although biochemical abnormalities have gained the most interest, variants in the mitochondrial genome could be one of the mechanisms underlying the phenotypic variability in ADPKD. This narrative review aims to evaluate the role of the mitochondrial genome in the pathogenesis of APDKD.